[Do initial experience with an enhanced recovery program after surgery (ERAS) improve postoperative outcomes after cystectomy?]

To estimate the feasibility and the impact of an ERAS program after radical cystectomy for bladder cancer.

This was a retrospective study comparing a historical pre ERAS group, including all the patients undergoing cystectomy for bladder cancer from January 2013 to December 2015 with a classic procedure, and an interventional ERAS group after introducing an enhanced recovery protocol before, during and after surgery, from February 2016. The principal outcome was the postoperative length of stay. Secondary outcomes mesures were impact on perioperative complication rate (Clavien classification≥3B), readmission rate, reanimation length of stay, ileus rate and adherence to the ERAS protocol.

There were no differences between the 2 groups as far as demographics characteristics are concerned. In total, 97 patients were included, 56 in the control group, and 41 in the ERAS group. The adherence to the protocol was about 65.8%. The ERAS group had statistically significantly shorter median length of stay (D19 versus D14; P: 0.021). The major complications rate (Clavien≥3B) were about 23.2% for the control group and 12.1% for the ERAS group (P: NS). The reinsertion of nasogastric tube were higher in the control group (39.3% vs 21.9%; P: NS) and the readmission rate was about 7.1% in the control group versus 14.6% in the ERAS group (P: NS).

In conclusion, introduction and application of an enhanced recovery protocol (ERAS) after cystectomy for bladder cancer allowed for better management of postoperative outcomes. It is clearly feasible in cystectomy, and improve significantly the median postoperative length of stay. Moreover, it may be effective in terms of faster return of bowel function and reduction of majors complications.

4.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2018 Apr 26 [Epub ahead of print]

A Baldini, H Fassi Fehri, Y Cerantola, F Bayle, E Ravier, P Y Belot, N Arnouil, M Colombel, L Badet

Hôpital Édouard-Herriot, 5, place d'Arsonval, 69003 Lyon, France. Electronic address: ., Hôpital Édouard-Herriot, 5, place d'Arsonval, 69003 Lyon, France. Electronic address: ., CHU Vaudois, 46, rue du Bugnon, 1011 Lausanne, Suisse. Electronic address: ., Hôpital Édouard-Herriot, 5, place d'Arsonval, 69003 Lyon, France. Electronic address: ., Rhena clinique de Strasbourg, 15, boulevard Ohmacht, 67000 Strasbourg, France. Electronic address: ., Hôpital Édouard-Herriot, 5, place d'Arsonval, 69003 Lyon, France. Electronic address: ., Hôpital Édouard-Herriot, 5, place d'Arsonval, 69003 Lyon, France. Electronic address: ., Hôpital Édouard-Herriot, 5, place d'Arsonval, 69003 Lyon, France. Electronic address: ., Hôpital Édouard-Herriot, 5, place d'Arsonval, 69003 Lyon, France. Electronic address: .